Synthesis, biological evaluation, and in silico studies of phenyl naphthalene-2-sulfonate derived thiosemicarbazones as potential carbonic anhydrase inhibitors
Javeria Eshal,
No information about this author
Hafiza Zara Tariq,
No information about this author
Jing Li
No information about this author
et al.
Bioorganic Chemistry,
Journal Year:
2025,
Volume and Issue:
155, P. 108118 - 108118
Published: Jan. 4, 2025
Language: Английский
Synthesis of new fluorinated sulfonates and their Schiff bases as anti-Alzheimer drug candidates: An in vitro-in silico study
Journal of Molecular Structure,
Journal Year:
2025,
Volume and Issue:
unknown, P. 141474 - 141474
Published: Jan. 1, 2025
Language: Английский
Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors
RSC Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Dual
acting
carbonic
anhydrase
modulators
with
monoamine
oxidase
and
cholinesterase
inhibitors.
Language: Английский
Design, synthesis of antipyrine-based Schiff bases and investigation of their cholinesterase and carbonic anhydrase activities by in vitro and in silico approaches
Journal of Molecular Structure,
Journal Year:
2024,
Volume and Issue:
unknown, P. 140599 - 140599
Published: Nov. 1, 2024
Language: Английский
(Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide as carbonic anhydrase inhibitor: exploration of its in vitro and in silico studies
Aftab Ahmed,
No information about this author
Sara Ilyas,
No information about this author
Pervaiz Ali Channar
No information about this author
et al.
BMC Chemistry,
Journal Year:
2025,
Volume and Issue:
19(1)
Published: March 10, 2025
Human
Carbonic
Anhydrase
inhibitors
(CAIs)
have
been
clinically
used
to
treat
a
variety
of
disorders,
such
as
cancer,
obesity,
haemolytic
anaemia,
glaucoma,
retinopathy,
and
epilepsy.
To
develop
inhibitor,
Iminothiazoline
analogue
((Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide)
was
synthesized
characterized.
Single
crystal
X-Ray
diffraction
studies
Hirshfeld
surface
analysis
(HSA)
were
conducted
find
the
exact
molecular
structure
well
intermolecular
interactions.
DFT
Calculations
indicated
soft
reactive
nature
molecule.
In-Vitro
carbonic
anhydrase
inhibition
showed
excellent
potential
(Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide
(IC50
value
0.147
±
0.03
µM).
Four
hydrogen
bonds
multiple
hydrophobic
interactions
observed
between
molecule
enzyme
during
Molecular
docking
studies.
dynamic
simulation
that
Protein–ligand
complex
generally
remained
stable
throughout
time.
ADMET
suggested
need
structural
modification
for
drug
like
behavior
Language: Английский
Some Novel Oxirane-Thiirane Derivatives: Synthesis, Molecular docking and Enzymatic Inhibition for Therapeutic Potential
Vagif Farzaliyev,
No information about this author
Adem Ertürk,
No information about this author
A.T. Huseynova
No information about this author
et al.
Cell Biochemistry and Biophysics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 7, 2025
Language: Английский
Acetylcholinesterase Inhibitors from Carbamate and Benzo-fused Heterocyclic Scaffolds: Promising Therapeutics for Alzheimer’s Disease
Amarjith Thiyyar Kandy,
No information about this author
R. Venkatesan,
No information about this author
David Mohan
No information about this author
et al.
Medicinal Chemistry Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 18, 2025
Language: Английский
New Sulfonate Ester‐Linked Fluorinated Hydrazone Derivatives as Multitarget Carbonic Anhydrase and Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, Molecular Docking and ADME Analysis
Berna Akış,
No information about this author
Reşit Çakmak,
No information about this author
Murat Şentürk
No information about this author
et al.
Chemistry & Biodiversity,
Journal Year:
2024,
Volume and Issue:
21(12)
Published: Aug. 19, 2024
Abstract
In
this
study,
some
new
hydrazone
derivatives
(
2a
–
g
)
was
designed,
synthesized
for
first
time,
and
evaluated
as
multitarget
inhibitors
of
AChE,
BChE,
hCA
I
II.
The
chemical
structures
hybrids
were
confirmed
by
elemental
analysis
spectroscopic
techniques.
All
tested
compounds
showed
low
nanomolar
inhibition
with
IC
50
values
in
the
range
30.4–264.0
nM
against
I,
23.2–251.6
II,
12.1–114.3
76.4–134.0
BChE.
These
inhibited
AChE
more
than
acetazolamide
(AZA)
neostigmine.
Among
them,
2c
2e
,
which
have
a
linear
structure,
determined
to
be
most
active
inhibitor
candidates
these
selected
enzymes.
Molecular
docking
studies
carried
out
on
2a‐
‐
),
revealing
their
binding
interactions
site
II
thus
supporting
experimental
findings.
Additionally,
silico
absorption,
distribution,
metabolism,
excretion
(ADME)
prediction
obtained
approaches
determine
solubility,
whether
they
potential
cross
blood‐brain
barrier
(BBB),
such
GI
absorption
drug
likeness
principles.
Language: Английский